These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 1695528)

  • 41. Assessing estrogen and progesterone receptor status in fine needle aspirates from breast carcinomas. Results on six years of material and correlation with biochemical assay.
    Sauer T; Beraki E; Jebsen PW; Amlie E; Harbitz T; Kåresen R; Naess O
    Anal Quant Cytol Histol; 1998 Apr; 20(2):122-6. PubMed ID: 9569969
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prognostic usefulness of estrogen receptor immunocytochemical assays for human breast cancer.
    DeSombre ER; Thorpe SM; Rose C; Blough RR; Andersen KW; Rasmussen BB; King WJ
    Cancer Res; 1986 Aug; 46(8 Suppl):4256s-4264s. PubMed ID: 2425944
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Determination of oestrogen receptors with monoclonal antibodies in fine needle aspirates of breast carcinoma.
    Marrazzo A; La Bara G; Taormina P; Bazan P
    Br J Cancer; 1989 Mar; 59(3):426-8. PubMed ID: 2930709
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparison of biochemical and immunoenzymatic macromethods and a new immunocytochemical micromethod for assaying estrogen receptors in human breast carcinomas.
    Devleeschouwer N; Faverly D; Kiss R; Legros N; de Launoit Y; Ryckaert C; Andry M; Lenglet G; Paridaens R; Gompel CM
    Acta Cytol; 1988; 32(6):816-24. PubMed ID: 2462316
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Estrogen receptor enzyme immunoassay in fine-needle aspirates from human breast cancer.
    Borg A; Fernö M; Idvall I
    Acta Oncol; 1989; 28(2):187-91. PubMed ID: 2660861
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of four immunochemical methods for the measurement of oestrogen receptor levels in breast cancer.
    Ryde CM; Smith D; King N; Trott PA; MacLennan K; McKinna JA; Minasian H; Dowsett M
    Cytopathology; 1992; 3(3):155-60. PubMed ID: 1511120
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Use of monoclonal antiestrogen receptor antibody to evaluate estrogen receptor content in fine needle aspiration breast biopsies.
    Flowers JL; Burton GV; Cox EB; McCarty KS; Dent GA; Geisinger KR; McCarty KS
    Ann Surg; 1986 Mar; 203(3):250-4. PubMed ID: 3954477
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Immunocytochemical evaluation of estrogen receptor on archival Papanicolaou-stained fine-needle aspirate smears.
    Krishnamurthy S; Dimashkieh H; Patel S; Sneige N
    Diagn Cytopathol; 2003 Dec; 29(6):309-14. PubMed ID: 14648786
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Correlation of estrogen receptor levels with histology and cytomorphology in human mammary cancer.
    Antoniades K; Spector H
    Am J Clin Pathol; 1979 May; 71(5):497-503. PubMed ID: 222129
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Detection of estrophilin in frozen sections of breast cancers using an estrogen receptor immunocytochemical assay.
    Ozzello L; De Rosa CM; Konrath JG; Yeager JL; Miller LS
    Cancer Res; 1986 Aug; 46(8 Suppl):4303s-4307s. PubMed ID: 2425948
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Estrogen receptor expression in benign breast ductal cells obtained from random periareolar fine needle aspiration correlates with menopausal status and cytomorphology index score.
    Sharma P; Kimler BF; Warner C; Metheny T; Xue Q; Zalles CM; Fabian CJ
    Breast Cancer Res Treat; 2006 Nov; 100(1):71-6. PubMed ID: 16791479
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Enzyme immunoassay of estrogen receptors in fine needle aspirates of breast tumors.
    Magdelenat H; Merle S; Zajdela A
    Cancer Res; 1986 Aug; 46(8 Suppl):4265s-4267s. PubMed ID: 3524807
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Anti-estradiol immunoperoxidase labeling of nuclei, not cytoplasm, in paraffin sections, determines estrogen receptor status of breast cancer.
    O'Keane JC; Okon E; Moroz K; Burke B; Sheahan K; O'Brien MJ
    Am J Surg Pathol; 1990 Feb; 14(2):121-7. PubMed ID: 2154140
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Determination of estrogen receptor by monoclonal antireceptor antibody in aspiration biopsy cytology from breast carcinoma.
    Keshgegian AA; Inverso K; Kline TS
    Am J Clin Pathol; 1988 Jan; 89(1):24-9. PubMed ID: 3276143
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The use of fine needle aspirates in the evaluation of progesterone receptor content in breast cancer.
    Lozowski M; Greene GL; Sadri D; Stanick D; Pai P; Harris MA; Lundy J
    Acta Cytol; 1990; 34(1):27-30. PubMed ID: 2404374
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Potential value of estrogen receptor immunocytochemical assay in formalin-fixed breast tumors.
    Masood S; Lu L; Rodenroth N
    Mod Pathol; 1990 Nov; 3(6):724-8. PubMed ID: 1702213
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Determination of estrogen receptors in cytologic imprints of breast cancers using immunocytochemical methods.
    Deligeorgi-Politi H; Bartziota EV; Mavrogeorgis A; Sekeris CE
    Acta Cytol; 1990; 34(6):881-4. PubMed ID: 1701608
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Presurgical determination of estrogen receptor status using immunocytochemically stained fine needle aspirate smears in patients with breast cancer.
    McClelland RA; Berger U; Wilson P; Powles TJ; Trott PA; Easton D; Gazet JC; Coombes RC
    Cancer Res; 1987 Nov; 47(22):6118-22. PubMed ID: 2444337
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Immunocytochemical assay for oestrogen receptor in fine needle aspirates of breast cancer by video image analysis.
    Horsfall DJ; Jarvis LR; Grimbaldeston MA; Tilley WD; Orell SR
    Br J Cancer; 1989 Jan; 59(1):129-34. PubMed ID: 2547412
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Estimation of hormone receptor status in fine-needle aspirates and paraffin-embedded sections from breast cancer using the novel rabbit monoclonal antibodies SP1 and SP2.
    Cano G; Milanezi F; Leitão D; Ricardo S; Brito MJ; Schmitt FC
    Diagn Cytopathol; 2003 Oct; 29(4):207-11. PubMed ID: 14506673
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.